Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.77B
-
Number of holders
-
1452
-
Total 13F shares, excl. options
-
1.11B
-
Shares change
-
+45M
-
Total reported value, excl. options
-
$62.7B
-
Value change
-
+$2.58B
-
Put/Call ratio
-
0.72
-
Number of buys
-
632
-
Number of sells
-
-642
-
Price
-
$56.44
Significant Holders of AbbVie Inc. - Common Stock (ABBV) as of Q2 2014
1,556 filings reported holding ABBV - AbbVie Inc. - Common Stock as of Q2 2014.
AbbVie Inc. - Common Stock (ABBV) has 1,452 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.11B shares
of 1.77B outstanding shares and own 62.82% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (103M shares), VANGUARD GROUP INC (85.7M shares), State Street Corp (70M shares), FMR LLC (57.1M shares), BlackRock Institutional Trust Company, N.A. (43.5M shares), Bank of New York Mellon Corp (25.7M shares), NORTHERN TRUST CORP (25.4M shares), BANK OF AMERICA CORP /DE/ (19.7M shares), Capital World Investors (19.7M shares), and JANUS CAPITAL MANAGEMENT LLC (17.1M shares).
This table shows the top 1452 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.